ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

Lippman Named UCSD Cancer Center Director

May 4, 2012

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

Spring Meetings Will Concentrate Everyone In New Orleans – Except The Nurses

March 25, 1988

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007